Should Value Investors Pick Preferred Bank (PFBC) Stock?
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value?
One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process. Let’s put Preferred Bank PFBC stock into this equation and find out if it is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks:
A key metric that value investors always look at is the Price to Earnings Ratio, or PE for short. This shows us how much investors are willing to pay for each dollar of earnings in a given stock, and is easily one of the most popular financial ratios in the world. The best use of the PE ratio is to compare the stock’s current PE ratio with: a) where this ratio has been in the past; b) how it compares to the average for the industry/sector; and c) how it compares to the market as a whole.
On this front, Preferred Bank has a trailing twelve months PE ratio of 9.61, as you can see in the chart below:
This level actually compares pretty favorably with the market at large, as the PE for the S&P 500 compares in at about 17.58. If we focus on the stock’s long-term PE trend, the current level puts Preferred Bank’s current PE ratio somewhat below its midpoint (which is 15.36) over the past five years.
Further, the stock’s PE also compares favorably with the Zacks Finance sector’s trailing twelve months PE ratio, which stands at 14.07. At the very least, this indicates that the stock is relatively undervalued right now, compared to its peers.
We should also point out that Preferred Bank has a forward PE ratio (price relative to this year’s earnings) of just 8.90, so it is fair to say that a slightly more value-oriented path may be ahead for Preferred Bank’s stock in the near term too.
An often overlooked ratio that can still be a great indicator of value is the price/cash flow metric. This ratio doesn’t take amortization and depreciation into account, so can give a more accurate picture of the financial health in a business. This is a preferred metric to some valuation investors because cash flows are (a) generally less prone to manipulation by the company’s management and (b) are less affected by variation in accounting policies between different companies.
The ratio is generally applied to find out whether a company’s stock is overpriced or underpriced with reference to its cash flows generation potential compared with its competitors. However, it is not commonly used for cross-industry comparison, as the average price to cash flow ratio varies from industry to industry.
In this case, Preferred Bank’s P/CF ratio of 7.27 is lower than the Zacks Banks – West industry average of 10.78, which indicates that the stock is somewhat undervalued in this respect.
Broad Value Outlook
In aggregate, Preferred Bank currently has a Value Style Score of A, putting it into the top 20% of all stocks we cover from this look. This makes PFBC a solid choice for value investors, and some of its other key metrics make this pretty clear too.
For example, the PEG ratio for Preferred Bank is just 0.89, a level that is considerably lower than the industry average of 1.49. The PEG ratio is a modified PE ratio that takes into account the stock’s earnings growth rate. Clearly, PFBC is a solid choice on the value front from multiple angles.
What About the Stock Overall?
Though Preferred Bank might be a good choice for value investors, there are plenty of other factors to consider before investing in this name. In particular, it is worth noting that the company has a Growth grade of B and a Momentum score of D. This gives PFBC a VGM score—or its overarching fundamental grade—of A. (You can read more about the Zacks Style Scores here >>)
Meanwhile, the company’s recent earnings estimates have been disappointing. The current quarter has seen two estimates go lower in the past sixty days compared to none higher, while the full year estimate has seen four downward and one upward revision in the same time period.
This has had a noticeable impact on the consensus estimate, as both the current quarter and full year consensus estimates have dipped 0.8% in the past two months. You can see the consensus estimate trend and recent price action for the stock in the chart below:
Preferred Bank Price and Consensus
This bearish trend is why the stock has just a Zacks Rank #3 (Hold) and why we are looking for in-line performance from the company in the near term.
Preferred Bank is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front. However, with a sluggish industry rank (bottom 14% out of more than 250 industries) and a Zacks Rank #3, it is hard to get too excited about this company overall. In fact, over the past one year, the sector has clearly underperformed the broader market, as you can see below:
So, value investors might want to wait for estimates, analyst sentiment and broader factors to turn favorable in this name first, but once that happens, this stock could be a compelling pick.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119%and +164%in as little as 1 month. The stocks in this report could perform even better.
Click to get this free report
Preferred Bank (PFBC): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.